Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)
China · Delayed Price · Currency is CNY 2.850
0.00 (0.00%)
Oct 22, 2025, 2:45 PM CST
SHA:600252 Revenue
Guangxi Wuzhou Zhongheng Group had revenue of 709.02M CNY in the quarter ending June 30, 2025, with 17.18% growth. This brings the company's revenue in the last twelve months to 2.31B, down -23.69% year-over-year. In the year 2024, Guangxi Wuzhou Zhongheng Group had annual revenue of 2.27B, down -26.67%.
Revenue (ttm)
2.31B
Revenue Growth
-23.69%
P/S Ratio
3.94
Revenue / Employee
777.82K
Employees
2,971
Market Cap
9.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.27B | -825.72M | -26.67% |
| Dec 31, 2023 | 3.10B | 382.77M | 14.10% |
| Dec 31, 2022 | 2.71B | -448.07M | -14.17% |
| Dec 31, 2021 | 3.16B | -514.55M | -14.00% |
| Dec 31, 2020 | 3.68B | -137.66M | -3.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |